Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 994-1004

  Hsu, C S ^a,b   Wang, P C ^a   Chen, J H ^a   Su, W C ^a   Tseng, T C ^a,b   Chen, H D ^a   Hsiao, T H ^a   Wang, C C ^a,b   Lin, H H ^a,b   Shyu, R Y ^a,b   Chao, Y C ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX DISEASE DIAGNOSTIC QUESTIONNAIRE; REFLUX ESOPHAGITIS; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TAIWAN; ULTRASONOGRAPHY;

EID: 80053205057     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04817.x     Document Type: Article

References (38)

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
2. Harish K, Dharmalingam M, Himanshu M,. Study Protocol: insulin and its role in cancer. BMC Endocr Disord 2007; 7: 10.
3. Hsing AW, Sakoda LC, Chua S Jr,. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007; 86: s843-57.
4. Xue F, Michels KB,. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86: s823-35.
5. Baillargeon J, Rose DP,. Obesity, adipokines, and prostate cancer (review). Int J Oncol 2006; 28: 737-45.
6. Cust AE, Kaaks R, Friedenreich C, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007; 14: 755-67. (Pubitemid 350074064)
7. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K,. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-91. (Pubitemid 34408218)
8. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
9. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-28. (Pubitemid 40523737)
10. Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360-5.
11. Moki F, Kusano M, Mizuide M, et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007; 26: 1069-75. (Pubitemid 47416298)
12. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-11. (Pubitemid 34465190)
13. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009; 58: 174-81.
14. Goh KL,. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol 2011; 26 (Suppl. 1): 2-10.
15. Lee YC, Wang HP, Chiu HM, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol 2006; 21: 798-804.
16. Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W,. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007; 132: 87-95. (Pubitemid 46108753)
17. Hsu CS, Wang CC, Wang PC, et al. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection. Hepatol Int 2010; 4: 585-93.
18. Bugianesi E, McCullough AJ, Marchesini G,. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42: 987-1000. (Pubitemid 43112663)
19. Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol 2008; 14: 5442-7.
20. Brown JJ, Naylor MJ, Yagan N,. Imaging of hepatic cirrhosis. Radiology 1997; 202: 1-16. (Pubitemid 27024101)
21. Cao Y, Yan X, Ma XQ, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol 2008; 8: 37.
22. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 52-7. (Pubitemid 32104807)
23. Alberti KG, Zimmet P, Shaw J,. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
24. He J, Neal B, Gu D, et al. International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis 2004; 14: 260-8. (Pubitemid 39302868)
25. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63. (Pubitemid 30022895)
26. Hsu CS, Liu CJ, Liu CH, et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008; 28: 271-7.
27. Wang CW, Lin HY, Shin SJ, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int 2011 [Epub ahead of print].
28. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92. (Pubitemid 26226887)
29. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004; 99: 1652-6. (Pubitemid 39237487)
30. Dickman R, Mattek N, Holub J, Peters D, Fass R,. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007; 102: 1173-9. (Pubitemid 46802000)
31. Fujiwara Y, Higuchi K, Shiba M, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005; 100: 754-8. (Pubitemid 40592362)
32. Ahmed AM, al Karawi MA, Shariq S, Mohamed AE,. Frequency of gastroesophageal reflux in patients with liver cirrhosis. Hepatogastroenterology 1993; 40: 478-80. (Pubitemid 23310270)
33. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R,. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
34. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008; 27: 173-85. (Pubitemid 350256608)
35. Soeters MR, Sauerwein HP, Groener JE, et al. Gender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab 2007; 92: 3646-52. (Pubitemid 47435351)
36. Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W, Thamprasit A,. Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. J Clin Endocrinol Metab 2004; 89: 6266-70. (Pubitemid 39628443)
37. Wilkin TJ, Murphy MJ,. The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance. Int J Obes (Lond) 2006; 30: 1056-61. (Pubitemid 43980572)
38. Nordenstedt H, Zheng Z, Cameron AJ, Ye W, Pedersen NL, Lagergren J,. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology 2008; 134: 921-8. (Pubitemid 351451964)